Product
Sitafloxacin
2 clinical trials
7 indications
Indication
COPD ExacerbationIndication
Anti-Infective AgentsIndication
UrinaryIndication
Escherichia coli infectionsIndication
Klebsiella infectionsIndication
Kidney TransplantIndication
Urinary Tract InfectionsClinical trial
A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseStatus: Recruiting, Estimated PCD: 2024-09-30